Search results for "Digitalization" in Articles / App Notes
								 					Article
				
				Security of Supply
								Getting high-quality biotherapeutics to patients on time requires a concerted effort. Working together, suppliers and manufacturers can better understand raw materials and variations that put processe…								
								 					Article
				
				Scaling Up Novel Therapies
								
	
		Scaling Up Novel Therapies
		
			Platform processes have improved monoclonal antibody scale-up. Can they do the same for personalized therapies? 
		
		
			
				
				
				  
			
			
				By Agnes S…								
								 					Article
				
				Preparing for the Future: Visions and Insights for Biomanufacturing
								The biopharmaceutical industry has a reputation of being averse to change. Yet, new market dynamics, such as growing competition from biosimilars and niche drugs targeting smaller patient populations,…								
								 					Article
				
				Roadmap Leads to Innovative Biomanufacturing Strategies
								However, newer standards may be required due to transformational changes likely to be brought in the move to full digitalization, big data analysis, machine intelligence, etc. Biomanufacturers can thu…								
								 					Article
				
				Evaluating Surface Cleanliness Using a Risk-Based Approach
								Evaluating Surface Cleanliness Using a Risk-Based Approach
	Rinse sample analysis or visual inspection can be correlated to surface cleanliness to replace surface sampling. 
	
		By Elizabeth Rivera…								
								 					Article
				
				Best Practices for Data Integrity
								
	
		Best Practices for Data Integrity
		
			Optimize practices and meet requirements using electronic data integrity systems. 
		
		
			
				By Jennifer Markarian 
			
			
				
			
			
				Maintainin…								
								 					Article
				
				Advanced Technologies Facilitate Scale-up and Technology Transfer
								
	Single-use and modular technologies plus continuous manufacturing are increasingly important to biopharma scale-up and tech transfer. 
	
	Jun 01, 2015 
	
	By Cynthia A. Challener 
	
	BioPharm Inte…								
								 					Article
				
				The Bullish Outlook for Biosimilars
								
	Feb 01, 2015 
	
	By Jill E. Sackman, PhD, Michael J. Kuchenreuther, PhD 
	
	BioPharm International 
	
	
	There are several important reasons for stakeholders to be optimistic about prospects for b…